Amazon Introduces Amazon Pharmacy: A Pharmaceutical Home Delivery Service
Making a big leap into the $312 billion US pharmacy industry, Amazon.com, Inc. (Amazon), has launched Amazon Pharmacy, a digital drugstore offering home delivery for prescription medication. Amazon Pharmacy will offer a range of generic and brand-name drugs. While Amazon Pharmacy will only initially be available in 45 US states, Amazon has announced its plans to expand the availability of Amazon Pharmacy in the near future.
Customers will be able to sign up for Amazon Pharmacy by creating a “secure pharmacy profile”. The profile will allow customers to add information about their health insurance, any outstanding medical issues, and any regular prescriptions. Amazon Prime members will get additional perks for joining Amazon Pharmacy. These perks include free, two-day delivery on orders, and discounts on medication. Amazon Pharmacy will accept “most” insurance plans. Interestingly, however, Amazon claims users, when paying without insurance, will be able to save up to 80 percent off of generic and 40 percent off of brand-name medications.
Amazon’s foray into the pharmaceutical industry is not entirely unexpected, as the Seattle-based company already has some experience in the sector. The online retailer sells medical equipment and supplies, as well as non-prescription drugs and other related goods in other nations, such as Japan. In 2018, the e-commerce giant bought pharmaceutical delivery start-up PillPack for just under US$1 billion. PillPack was later rebranded as PillPack by Amazon. PillPack delivers medications to customers with chronic conditions who are taking multiple daily medications. Nonetheless, PillPack’s infrastructure and relationships with healthcare providers coupled with Amazon’s prowess in logistics, and its network of warehouses and drivers, made Amazon’s entry into the pharmaceutical industry as a logical next step. The launch of Amazon Pharmacy comes at a time when more people are staying at home as a result of the COVID-19 pandemic, making the prospect of delivery medication more attractive to consumers.
With Amazon moving into almost every market there is, it will be interesting to see what steps the tech giant takes on next.
Author: Nargis Fazli
Photo Credit: https://unsplash.com/@tbelabuseridze
Expertise
Insights
-
Privacy and Data Protection
Canadian Privacy Regulators Publish Findings and Guidance on OpenAI Privacy Compliance
Following a multi-year joint investigation, federal and provincial privacy regulators recently published their findings with respect to OpenAI’s collection and use of personal information to train… -
Technology
Anthropic Prepares for Public Markets
Anthropic, one of the world’s leading AI firms, has confidentially submitted a draft S-1 registration statement to the U.S. Securities and Exchange Commission, paving the way for a potential initial… -
Technology
Blast-off: The Race to IPO in the American Technology Landscape
On May 20, 2026, Space Exploration Technologies Corp. (“SpaceX”) filed an S-1 form with the United States’ Securities and Exchange Commission, indicating its intention to launch an initial public… -
Technology
Humans: 0, Robot: 1 – Sony’s Project Ace Robot Beats the Pros
Developed by Sony AI, a new robot named Ace has outperformed elite table tennis players, marking a significant milestone in AI and robotics. While AI systems have previously rivalled or surpassed… -
Technology
TikTok Cleared to Continue Canadian Operations Following National Security Review
The Government of Canada (the “Government”) has concluded its most recent national security review of TikTok, the popular short-form video platform owned by Chinese technology company ByteDance Ltd… -
Technology
Confined Space Robotics Awarded $1.5M Contract to Automate Blast and Paint at Seaspan Shipyard
Confined Space Robotics (“CSR”) has been awarded a $1.5 million contract by Seaspan Shipyards to develop and integrate abrasive blast and paint robotic systems at Seaspan’s Vancouver shipyard. Seaspan…